TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 36^th Annual Healthcare Conference.

TELA’s management is scheduled to present at Piper Sandler’s 36^th Annual Healthcare Conference at 12:00 pm ET on December 3^rd, 2024. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010
[email protected]

You May Also Be Interested In

• Quebec Brokerage Qubit Insurance Announces New Data on Coverage Shortfalls as Rebuilding Costs Rise
• Dr. Ahdout Expands Its General, Cosmetic, and Implant Dentistry in Woodland Hills
• New Crypto: Pepeto Announces $10.96M Raised While Ethereum Price Prediction Climbs to $40,000